Stanley Black & Decker enters the second week of August riding an unusual tension: a 10% weekly gain that has pushed the stock decisively above the consensus analyst target, even as shorts quietly retreat and the lending market stays firmly in their corner.
The stock closed at $103.89 on Friday, up nearly 10% on the week and 16% over the past month. That move is the standout. Close peers TTC and OSK each gained around 9% on the week, suggesting the industrial machinery space broadly caught a bid — but SWK's year-to-date outperformance, now roughly 36%, keeps it well ahead of the group. TKR was the lone laggard, slipping 5% on the week, a contrast that sharpens the sense that the SWK rally is at least partly stock-specific.
The lending market frames the short side as cautious rather than pressed. Short interest has fallen sharply — down 22% over the past month to around 4% of the free float — and the borrow environment gives shorts no reason to panic. Availability runs at roughly 950% of outstanding short interest, meaning there are nearly ten shares available to borrow for every one already lent out. That figure has actually widened over the past week, easing from around 870% at the start of August. Cost to borrow is running at 0.44%, which is close to nothing. The ORTEX short score sits at 40.6, drifting lower from 41.8 at the start of last week, and ranks only in the 30th percentile on short score — not a setup where squeezes or borrow pressure are realistic concerns. The options market echoes the relaxed tone. The put/call ratio is 0.22, modestly above its 20-day average of 0.19 but less than one standard deviation away, and nowhere near the 52-week high of 0.67. Call-side dominance has been the persistent feature here for months.
The Street angle is where the week's real tension sits. The mean analyst price target is $96.91 — around 7% below Friday's close. Citi raised its target to $107 on July 31, the only bellwether move since earnings, and that is the sole target currently above the current price in the recent-changes data. JPMorgan holds an Underweight with a $75 target, Wells Fargo is at Equal-Weight with $90, and Morgan Stanley's Equal-Weight anchor is at $84. The analyst recommendation differential factor score ranks in the 100th percentile of the ORTEX universe — meaning the gap between current price and average target is as stretched as it gets. The valuation picture supports some of the scepticism: the trailing P/E has expanded to 17x, up nearly 1.7 points over the past month, while EV/EBITDA has contracted slightly to 11.4x as earnings estimates have held. The stock's value score — a standout pillar in the ORTEX stock score — was built on a sub-1.2x price-to-book reading; at current prices, P/B has climbed to 1.66x, compressing that margin of safety. The dividend data in the snapshot is stale and should not be treated as current.
Institutional ownership is steady rather than activist. The top holders — Capital Research, T. Rowe Price, State Street — have been adding in small increments. The most notable recent institutional shift is Adage Capital, which added over 1.5 million shares as of the last 13F filing, a meaningful position build from a smaller base. Insider activity in the window is dominated by equity awards to the two sitting CEOs and associated tax-cover sales — nothing that reads as directional conviction in either sense.
The next formal catalyst is earnings on October 28. The last print on July 29 produced a 1.4% one-day gain and a 9.6% five-day gain — a pattern worth keeping in mind. Between now and then, the question is whether the stock can consolidate above a consensus target that the market has already left behind, or whether analyst upgrades and target raises follow the price.
See the live data behind this article on ORTEX.
Open SWK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
